NKGen Biotech, Inc. NKGN
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 70.56% | -- | -- | -- | -180.56% |
| Total Depreciation and Amortization | 11.67% | -- | -- | -- | 1.24% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -95.22% | -- | -- | -- | 929.40% |
| Change in Net Operating Assets | -100.35% | -- | -- | -- | 754.44% |
| Cash from Operations | 6.74% | -- | -- | -- | 2.54% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -185.71% | -- | -- | -- | 43.09% |
| Cash from Investing | -- | -- | -- | -- | 100.00% |
| Total Debt Issued | -20.55% | -- | -- | -- | 0.13% |
| Total Debt Repaid | -1,479.53% | -- | -- | -- | 33.77% |
| Issuance of Common Stock | 211.04% | -- | -- | -- | 954.09% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 115.95% | -- | -- | -- | -- |
| Cash from Financing | -5.40% | -- | -- | -- | -6.88% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 45.04% | -- | -- | -- | -217.77% |